ATRA treatment in MCF-7 breast cancer cells reduce S100A10 but not annexin A2 transcript and protein levels, indicating that ATRA can regulate S100A10 levels independently of PML/RARα and annexin A2 [111]. This evidence concerns the gene S100A10 and breast carcinoma.